Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details)

v3.23.2
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Segment Reporting Information [Line Items]        
Net revenue $ 29,362 $ 37,228 $ 59,363 $ 72,569
Direct operating costs 17,476 21,787 35,583 44,460
Selling and marketing 2,580 2,426 5,192 4,810
General and administrative 5,916 6,394 11,036 11,979
Research and development 1,185 1,098 2,263 2,083
Change in contingent consideration (630) (1,230)
Depreciation and amortization 3,341 2,936 6,379 5,876
Net loss on lease terminations and unoccupied lease charges 153 463 422 621
Total operating expenses 30,651 34,474 60,875 68,599
OPERATING (LOSS) INCOME (1,289) 2,754 (1,512) 3,970
Healthcare IT [Member]        
Segment Reporting Information [Line Items]        
Net revenue 25,985 34,029 52,939 66,182
Direct operating costs 14,941 19,285 30,634 39,296
Selling and marketing 2,570 2,421 5,174 4,797
General and administrative 3,250 3,582 5,746 6,982
Research and development 1,185 1,098 2,263 2,083
Change in contingent consideration (630) (1,230)
Depreciation and amortization 3,251 2,847 6,200 5,699
Net loss on lease terminations and unoccupied lease charges 153 463 422 621
Total operating expenses 25,350 29,066 50,439 58,248
OPERATING (LOSS) INCOME 635 4,963 2,500 7,934
Medical Practice Management [Member]        
Segment Reporting Information [Line Items]        
Net revenue 3,377 3,199 6,424 6,387
Direct operating costs 2,535 2,502 4,949 5,164
Selling and marketing 10 5 18 13
General and administrative 448 420 896 857
Research and development
Change in contingent consideration
Depreciation and amortization 90 89 179 177
Net loss on lease terminations and unoccupied lease charges
Total operating expenses 3,083 3,016 6,042 6,211
OPERATING (LOSS) INCOME 294 183 382 176
Unallocated Corporate Expenses [Member]        
Segment Reporting Information [Line Items]        
Net revenue
Direct operating costs
Selling and marketing
General and administrative 2,218 2,392 4,394 4,140
Research and development
Change in contingent consideration
Depreciation and amortization
Net loss on lease terminations and unoccupied lease charges
Total operating expenses 2,218 2,392 4,394 4,140
OPERATING (LOSS) INCOME $ (2,218) $ (2,392) $ (4,394) $ (4,140)